A peer-reviewed journal would not survive without the generous time and insightful comments of the reviewers, whose efforts often go unrecognized. Although final decisions are always editorial, they are greatly facilitated by the deeper technical knowledge, scientific insights, understanding of social consequences, and passion that reviewers bring to our deliberations. For these reasons, the Editors and staff of Journal of Experimental & Clinical Cancer Research would like to publicly acknowledge our peer reviewers.
Reviewer acknowledgements
-
-
Owned by the Association for International Promotion & Study in Tumors (APSIT)
-
Official journal of the Regina Elena National Cancer Institute, Scientific Director Gennaro Ciliberto, Rome, Italy
-
- Editorial Board
- Manuscript editing services
- Instructions for Editors
- Sign up for article alerts and news from this journal
Annual Journal Metrics
-
Citation Impact 2023
Journal Impact Factor: 11.4
5-year Journal Impact Factor: 11.4
Source Normalized Impact per Paper (SNIP): 1.770
SCImago Journal Rank (SJR): 2.806Speed 2023
Submission to first editorial decision (median days): 5
Submission to acceptance (median days): 100Usage 2023
Downloads: 3,003,080
Altmetric mentions: 3,022